NCT04520386View on ClinicalTrials.gov

OMT-111 for Terminal Stage Solid Tumors

PHASE2UnknownINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

October 31, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

October 31, 2022

Conditions
Breast CancerPancreatic CancerLung Cancer
Interventions
DRUG

OMT-111

Pre-filled Syringe

Trial Locations (2)

Unknown

K Hospital, Hanoi

Cho Ray Hospital, Hochiminh City

Sponsors
All Listed Sponsors
lead

MetiMedi Pharmaceuticals

INDUSTRY

NCT04520386 - OMT-111 for Terminal Stage Solid Tumors | Biotech Hunter | Biotech Hunter